Supplementary Table 1.
: Mortality in HIV-positive vs HIV-negative patients.
| HIV-positiveDied | HIV-negativeDied | P value | |
| n = 16 | n = 54 | ||
| Age | |||
| Median (IQR), (years) | 47.5 (38.25–58.75) | 57 (46–65) | 0.06 |
| Gender | |||
| n (%) | |||
| Male | 8 (50%) | 33 (61%) | 0.56 |
| Female | 8 (50%) | 21 (39%) | |
| Race | |||
| n (%) | |||
| Black | 15 (94%) | 43 (80%) | |
| White | 0 (0%) | 7 (13%) | |
| Indian | 0 (0%) | 0 (0%) | |
| Mixed race | 1 (6%) | 4 (7%) | |
| Comorbidities | |||
| n (%) | |||
| Cardiovascular disease | 7 (43.75%) | 19 (35.19%) | 0.5662 |
| Chronic kidney disease | 3 (18.75%) | 5 (9.26%) | 0.3715 |
| Chronic liver disease | 1 (6.25%) | 2 (3.70%) | 0.5469 |
| Chronic lung disease | 0 (0%) | 2 (3.7%) | 1.0 |
| Diabetes Mellitus | 7 (43.75%) | 16 (29.63%) | 0.3664 |
| Dyslipidaemia | 1 (6.25%) | 4 (7.41%) | 1.0 |
| Malignancy | 1 (0%) | 4 (7.41%) | 1.0 |
| Neuropsychiatric disease | 3 (18.75%) | 1 (1.85%) | 0.0350 |
| Obesity | 1 (6.25%) | 17 (31.48%) | 0.0530 |
| Previous tuberculosis | 1 (6.25%) | 0 (0%) | 0.2286 |
| Rheumatological disease | 0 (0%) | 3 (5.56%) | 1.0 |
| Smoking | 3 (18.75%) | 1 (1.85%) | 0.0364 |
| Thyroid disease | 0 (0%) | 0 (0%) | 1.0 |
| Vitals | |||
| Median (IQR |
IQR – Interquartile range, ALT- Alanine transaminase, AST- Aspartate transaminase, ALP - Alkaline phosphatase, GGT - Gamma-glutamyl transferase, LDH – lactate dehydrogenase, N/L – neutrophil/lymphocyte, hs – Highly sensitive, PTED – Pulmonary thrombo-embolic disease.